Literature DB >> 33778504

Prognosis of CT-derived Fractional Flow Reserve in the Prediction of Clinical Outcomes.

Charis G McNabney1, Stephanie L Sellers1, Ryan J A Wilson1, Shmuel Hart1, Samuel A Rosenblatt1, Darra T Murphy1, Philipp Blanke1, Amir A Ahmadi1, Jaydeep Halankar1, Adrian Attinger-Toller1, Marcelo Godoy Zamorano1, Janice Wong Li Yu1, Bjarne L Nørgaard1, Jonathon A Leipsic1, Jonathan R Weir-McCall1.   

Abstract

PURPOSE: To examine the prognostic implication of fractional flow reserve (FFR) derived from coronary CT (FFRCT) in routine clinical practice.
MATERIALS AND METHODS: Patients referred for FFRCT analysis at a single center between October 2015 and June 2017 were retrospectively included and followed up for rates of invasive angiography and clinical events. Two hundred seven patients underwent successful FFRCT analysis with seven lost to follow-up, leaving 200 (mean age ± standard deviation, 62.4 years ± 10.0; 49 [24.5%] women) patients for analysis. At coronary CT angiography, patients were categorized as having significant stenosis (SS) in the presence of a diameter stenosis greater than or equal to 50% (hereafter, SS positive) and flow limitation in the presence of a postlesion (that is, FFRCT measured 2 cm to the distal aspect of the lesion) FFRCT less than 0.80 (hereafter, FFRCT positive). Vessel-oriented clinical events (VOCEs) were defined as vessel-related late revascularization (>90 days), myocardial infarction, and cardiac mortality.
RESULTS: At CT angiography, 130 (65%) studies were SS positive and 63 (31.5%) were FFRCT positive. At median follow-up of 477 days (range, 252-859 days), there were 26 VOCE end points in 22 patients: 22 revascularizations and four nonfatal myocardial infarctions. VOCE end points occurred in zero of 58 (0%) of SS-negative and FFRCT negative patients, in eight of 79 (10.1%) of SS-positive and FFRCT-negative patients, in zero of 12 (0%) of SS-negative and FFRCT-positive patients, and in 18 of 51 (35.3%) of SS-positive and FFRCT-positive patients (log-rank χ2 = 30.1; P < .001). At multivariable Cox regression, both FFRCT (hazard ratio per 0.1 decrease, 1.54 [95% confidence interval: 1.1, 2.2] P = .013) and stenosis (hazard ratio per unit increase, 2.16 [95% confidence interval: 1.25, 3.72] P = .006) were independently associated with VOCE.
CONCLUSION: Stenosis and FFRCT are independent predictors of intermediate-term outcomes. In the absence of a stenosis greater than 50%, a positive FFRCT result is not associated with an increased intermediate risk.© RSNA, 2019Supplemental material is available for this article.See also commentary by Fairbairn and Bull in this issue. 2019 by the Radiological Society of North America, Inc.

Entities:  

Year:  2019        PMID: 33778504      PMCID: PMC7970101          DOI: 10.1148/ryct.2019190021

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  25 in total

1.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.

Authors:  Nico H J Pijls; William F Fearon; Pim A L Tonino; Uwe Siebert; Fumiaki Ikeno; Bernhard Bornschein; Marcel van't Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2010-05-28       Impact factor: 24.094

2.  Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

Authors:  Nils P Johnson; Gábor G Tóth; Dejian Lai; Hongjian Zhu; Göksel Açar; Pierfrancesco Agostoni; Yolande Appelman; Fatih Arslan; Emanuele Barbato; Shao-Liang Chen; Luigi Di Serafino; Antonio J Domínguez-Franco; Patrick Dupouy; Ali M Esen; Ozlem B Esen; Michalis Hamilos; Kohichiro Iwasaki; Lisette O Jensen; Manuel F Jiménez-Navarro; Demosthenes G Katritsis; Sinan A Kocaman; Bon-Kwon Koo; Ramón López-Palop; Jeffrey D Lorin; Louis H Miller; Olivier Muller; Chang-Wook Nam; Niels Oud; Etienne Puymirat; Johannes Rieber; Gilles Rioufol; Josep Rodés-Cabau; Steven P Sedlis; Yasuchika Takeishi; Pim A L Tonino; Eric Van Belle; Edoardo Verna; Gerald S Werner; William F Fearon; Nico H J Pijls; Bernard De Bruyne; K Lance Gould
Journal:  J Am Coll Cardiol       Date:  2014-10-21       Impact factor: 24.094

3.  Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry.

Authors:  Hironori Kitabata; Jonathon Leipsic; Manesh R Patel; Koen Nieman; Bernard De Bruyne; Campbell Rogers; Gianluca Pontone; Bjarne L Nørgaard; Jeroen J Bax; Gilbert Raff; Kavitha M Chinnaiyan; Mark Rabbat; Niels Peter Rønnow Sand; Philipp Blanke; Timothy A Fairbairn; Hitoshi Matsuo; Tetsuya Amano; Tomohiro Kawasaki; Yoshihiro Morino; Takashi Akasaka
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-02-02

4.  1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.

Authors:  Pamela S Douglas; Bernard De Bruyne; Gianluca Pontone; Manesh R Patel; Bjarne L Norgaard; Robert A Byrne; Nick Curzen; Ian Purcell; Matthias Gutberlet; Gilles Rioufol; Ulrich Hink; Herwig Walter Schuchlenz; Gudrun Feuchtner; Martine Gilard; Daniele Andreini; Jesper M Jensen; Martin Hadamitzky; Karen Chiswell; Derek Cyr; Alan Wilk; Furong Wang; Campbell Rogers; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2016-08-02       Impact factor: 24.094

5.  Clinical Use of Coronary CTA-Derived FFR for Decision-Making in Stable CAD.

Authors:  Bjarne L Nørgaard; Jakob Hjort; Sara Gaur; Nicolaj Hansson; Hans Erik Bøtker; Jonathon Leipsic; Ole N Mathiassen; Erik L Grove; Kamilla Pedersen; Evald H Christiansen; Anne Kaltoft; Lars C Gormsen; Michael Mæng; Christian J Terkelsen; Steen D Kristensen; Lars R Krusell; Jesper M Jensen
Journal:  JACC Cardiovasc Imaging       Date:  2016-04-13

6.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

7.  Fractional flow reserve derived from coronary computed tomography angiography reclassification rate using value distal to lesion compared to lowest value.

Authors:  Shaw Hua Kueh; John Mooney; Mickaël Ohana; Ung Kim; Philipp Blanke; Rominder Grover; Stephanie Sellers; Jennifer Ellis; Darra Murphy; Cameron Hague; Jeroen J Bax; Bjarne L Nørgaard; Mark Rabbat; Jonathon A Leipsic
Journal:  J Cardiovasc Comput Tomogr       Date:  2017-09-21

8.  Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).

Authors:  Bjarne L Nørgaard; Jonathon Leipsic; Sara Gaur; Sujith Seneviratne; Brian S Ko; Hiroshi Ito; Jesper M Jensen; Laura Mauri; Bernard De Bruyne; Hiram Bezerra; Kazuhiro Osawa; Mohamed Marwan; Christoph Naber; Andrejs Erglis; Seung-Jung Park; Evald H Christiansen; Anne Kaltoft; Jens F Lassen; Hans Erik Bøtker; Stephan Achenbach
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

9.  Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography.

Authors:  Jesper Møller Jensen; Hans Erik Bøtker; Ole Norling Mathiassen; Erik Lerkevang Grove; Kristian Altern Øvrehus; Kamilla Bech Pedersen; Christian Juhl Terkelsen; Evald Høj Christiansen; Michael Maeng; Jonathon Leipsic; Anne Kaltoft; Lars Jakobsen; Jacob Thorsted Sørensen; Troels Thim; Steen Dalby Kristensen; Lars Romer Krusell; Bjarne Linde Nørgaard
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-04-01       Impact factor: 6.875

10.  Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.

Authors:  Pamela S Douglas; Gianluca Pontone; Mark A Hlatky; Manesh R Patel; Bjarne L Norgaard; Robert A Byrne; Nick Curzen; Ian Purcell; Matthias Gutberlet; Gilles Rioufol; Ulrich Hink; Herwig Walter Schuchlenz; Gudrun Feuchtner; Martine Gilard; Daniele Andreini; Jesper M Jensen; Martin Hadamitzky; Karen Chiswell; Derek Cyr; Alan Wilk; Furong Wang; Campbell Rogers; Bernard De Bruyne
Journal:  Eur Heart J       Date:  2015-09-01       Impact factor: 29.983

View more
  1 in total

1.  Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.

Authors:  Bjarne L Nørgaard; Sara Gaur; Timothy A Fairbairn; Pam S Douglas; Jesper M Jensen; Manesh R Patel; Abdul R Ihdayhid; Brian S H Ko; Stephanie L Sellers; Jonathan Weir-McCall; Hitoshi Matsuo; Niels Peter R Sand; Kristian A Øvrehus; Campbell Rogers; Sarah Mullen; Koen Nieman; Erik Parner; Jonathon Leipsic; Jawdat Abdulla
Journal:  Heart       Date:  2021-10-22       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.